Sesen Bio, Inc. (NASDAQ:SESN)
Sesen Bio, Inc. (NASDAQ:SESN) represented a move of 20.78 percent or $-0.11 per share and closed its previous day trading session at $1.86. 5.16 Million Shares were traded in the last trading session with an Average Volume of 999.4 Million Shares. The stock currently has a Market Capitalization of 141.47 Million.
Sesen Bio Inc. is a late-stage company developing next-generation antibody-drug conjugate therapies for patients with cancer. The company’s product portfolio includes Vicinium(TM) which is in its clinical trial, treats high-grade non-muscle invasive bladder cancer. Sesen Bio Inc., formerly known as Eleven Biotherapeutics, is based in Massachusetts, United States.
The stock traded between $0.62 and $3.50 over 1-Year time period showing its price to sales ratio of 0. Sesen Bio, Inc. (NASDAQ:SESN) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-1.56 and 200-Day Simple Moving Average of $4.6. Its Price to Free Cash Flow is 0 and Price to Book of 1.63.
Analyst’s recommended the stock as 1.5 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Sesen Bio, Inc. (NASDAQ:SESN) reported its Actual EPS of $-0.16/share. The analysts offering Earnings Estimates for the company were believing that Sesen Bio, Inc. could bring EPS of $-0.14/share. The difference between Actual EPS and Estimated EPS was -0.02 Percent. Thus showing an Earnings Surprise of -14.3 Percent.
MasTec, Inc. (NYSE:MTZ)
In the last trading session, MasTec, Inc. (NYSE:MTZ) added its value by 3.49% closing at the price of $50.67. The stock currently has market capitalization of 3.84 Billion, with average volume of 1.33 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently MasTec, Inc. (NYSE:MTZ) is showing beta of 1.45. This particular value of beta suggests that MasTec, Inc. (NYSE:MTZ) has historically moved 145% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for MasTec, Inc. (NYSE:MTZ) is at $2.59.
The stock currently has RSI of 72.54. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
MASTEC INC. is one of the largest providers of construction services to the telecommunications industry in the United States. The Company’s principal business consists of the installation and maintenance of aerial, underground and buried copper and fiber optic cable, underground conduit, manhole systems and relatessed construction for local telephone companies, including Regional Bell Operating Companies such as BellSouth Telecommunications, Inc., U.S. West, Inc. and SBC Communications, Inc., and non-Bell local telephone companies such as Sprint Corp., and GTE Corp.
MasTec, Inc. (NYSE:MTZ) topped its 52-week high price of $55.53 on 02/01/18 and 52-Week Low Price of $39.83 on 11/15/17. The Stock currently has P/E (price to earnings ttm) of 19.55 and Weekly volatility of 4.26% and monthly volatility of 3.86% respectively.